Dr. Andrew D. Breithaupt, MD

Dr. Breithaupt practices at Orchard Creek Surgery Center - Mountain View in Mountain View, California.

Dr. Breithaupt's NPI, 1437460359, was assigned on June 25, 2010. Dr. Breithaupt graduated from UC San Diego School of Medicine in 2010. Dr. Breithaupt holds California license A118094.

Dr. Breithaupt's primary practice is Orchard Creek Surgery Center - Mountain View, at 525 South Drive, Suite 115, Mountain View, CA 94040. The practice phone is (650) 969-5600.

Dr. Breithaupt's primary practice is Orchard Creek Surgery Center - Mountain View in Mountain View, California. The medical group on file is Schweiger Dermatology Group, San Pedro. Dmand AI also links Dr. Breithaupt to 6 more group practices and clinics and 6 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Breithaupt practices, 7 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Breithaupt's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Breithaupt is board certified in dermatology by the American Board of Dermatology. Dr. Breithaupt is licensed in California.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes, minor injury to a limb, scalp rash and shingles among the conditions Dr. Breithaupt treats.

CMS data shows 5,678 Medicare services from Dr. Breithaupt across 35 procedure codes in 2024, for 795 Medicare patients. Medicare paid $1,677,575 for them. Every service was in an office.

CMS counts 795 Medicare patients who saw Dr. Breithaupt in 2024. The largest group is 75 to 84, with 365 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 2% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Breithaupt's median patient age at 76, with 41% women.

In 2024, Dr. Breithaupt wrote 548 Medicare Part D claims for 348 patients. 99% of them were for generic drugs. CMS names the drug for 459 of them, across 8 drugs with 11 or more claims each, at $3,607 in total drug cost. In 2023, CMS named 187 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Breithaupt for performance year 2024, reported individually. Dr. Breithaupt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,832 procedures of removal of skin cancer by Dr. Breithaupt, more than 99% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Breithaupt in 2015. Dr. Breithaupt's most frequent co-authors are Tiffany L. Anthony, MD, Sarah Tuttleton Arron, MD, PhD and Gordon Hyeonjin Bae, MD.

CMS Open Payments shows 267 general payments to Dr. Breithaupt from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 49% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $3,497.

Dr. Breithaupt graduated from UC San Diego School of Medicine in 2010.

Dr. Breithaupt is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.